New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black ...

Mechanical thrombectomy (MT), another invasive treatment method has been shown to reduce thrombus burden and pulmonary artery ...

mitochondrial abnormalities and thrombosis are the dominant underlying pathobiologic processes of pulmonary arterial hypertension (PAH). In addition to conventional and supportive therapies ...

Share on Pinterest After years of living with worsening symptoms from pulmonary arterial hypertension, Heather Kauffman’s (right) life changed when she joined a clinical trial for the new ...

A pulmonary embolism is a blockage in the pulmonary artery that supplies blood to the lungs. The blockage, usually caused by a blood clot, impairs oxygenation of the blood and can damage the heart.

For pulmonary arterial hypertension, currently marketed methods of treprostinil administration include intravenous, subcutaneous and inhalation. Oral treprostinil is actively being investigated.

Over 150 experts and patient representatives from across globe came together at Ferrer’s IMPAHCT conference 2024 to address ...

The approval, which marks the first for a once-daily, single-tablet combination therapy for pulmonary arterial hypertension, is based on findings from the phase 3 A DUE study. About 17 million ...

Mere weeks after earning the FDA’s signoff on new drug Winrevair to treat pulmonary arterial hypertension (PAH), Merck has kicked off an educational campaign around the rare disease. The ...

Anticipated growth for ‘Saudi Arabia Pulmonary Arterial Hypertension Market’ is significant from 2024 to 2032. The market ...

Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...